In general, when you receive hormone replacement therapy, you're taking estrogen and progesterone. These hormones are linked to several types of cancer. These hormones are linked to several types of cancer, including breast cancer and endometrial cancer. Hormonal hormone therapy may slightly increase the risk of breast cancer.
If you've had breast cancer, you'll usually be advised not to take HRT. There are also lifestyle changes that can lower the risk of breast cancer. Some studies show that using hormonal hormone therapy with estrogen and progesterone for more than 10 years may increase the risk of breast cancer. It is recommended to take hormone replacement therapy only for as long as needed or until menopausal symptoms disappear.
It's important to understand the risks associated with hormone replacement therapy before making the decision to take it. The risks are different for each person and are influenced by factors such as personal health history, age, the length of time a person takes hormone replacement therapy, dosage and type. Research shows that long-term use of combination hormone therapy (for 5 years or more) slightly increases the risk of breast and ovarian cancer, heart disease, stroke, and pulmonary embolism (blood clots in the lungs). Research also suggests that the benefits of taking combined hormone replacement therapy for the shortest period needed outweigh the risks for healthy women under 60 or within 10 years of the onset of menopause.
If you have or have ever had another type of cancer, hormone replacement therapy has the same risk for you as it does for people without cancer. Some hormone products, which may be referred to as bioidentical hormones, are available without a prescription. Here I'll share more information about hormone replacement therapy, its relationship to cancer risk, and how to decide if it's right for you.
During the post-intervention and extension phases, less than 2% of the women who participated in the trial with conjugated equine estrogen (CEE) plus medroxyprogesterone acetate (MPA) and less than 4% of the women who participated in the trial conducted with hormone therapy alone.
Estrogen therapy alone may increase the risk of endometrial cancer, but combining estrogen with progestogen (also known as progestogen) reduces this risk. If you are considering taking hormone replacement therapy, the Canadian Cancer Society recommends that you talk to your healthcare provider about how hormone therapy can alleviate menopausal symptoms and about your individual risks.There isn't enough research yet on the cancer risk associated with hormone therapies that are used in this way. To find out if menopausal hormone therapy is a good option for you, talk to your health professional about your symptoms and health risks. While not all women need to treat their symptoms, if the symptoms are severe enough, your doctor may recommend trying treatment, such as hormone replacement therapy (HRT), to reduce symptoms. Hormone therapy, or endocrine therapy, reduces or blocks certain hormones, such as estrogen, that the body creates and uses. Hormone replacement therapy (HRT), also known as menopausal hormone therapy (MHT), is a medication that replaces certain hormones that the body produces in smaller quantities as it progresses through perimenopause and menopause.
According to studies from the Women's Health Initiative and other research, in women without a history of breast cancer, the systemic administration of estrogen-only hormone therapy is not associated with an increased risk of breast cancer. While these therapies offer positive symptom relief for many people, they have also been associated with side effects, including an increased risk of breast cancer. To examine total and cause-specific cumulative mortality, including during intervention and extended post-intervention follow-up, in the two hormonal therapy trials of the Women's Health Initiative.
